A detailed history of Rtw Investments, LP transactions in 89bio, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 7,378,548 shares of ETNB stock, worth $55.2 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares
7,378,548
Previous 7,378,548 -0.0%
Holding current value
$55.2 Million
Previous $85.9 Million 31.19%
% of portfolio
0.99%
Previous 1.38%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$8.13 - $13.77 $14.6 Million - $24.8 Million
1,799,617 Added 32.26%
7,378,548 $85.9 Million
Q4 2023

Feb 14, 2024

BUY
$6.66 - $16.03 $37.2 Million - $89.4 Million
5,578,931 New
5,578,931 $62.3 Million

Others Institutions Holding ETNB

About 89bio, Inc.


  • Ticker ETNB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,484,500
  • Market Cap $348M
  • Description
  • 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...
More about ETNB
Track This Portfolio

Track Rtw Investments, LP Portfolio

Follow Rtw Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.